darexaban + Naproxen
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacodynamic Interaction
Conditions
Pharmacodynamic Interaction, Healthy Subjects
Trial Timeline
Jan 1, 2010 → May 1, 2010
NCT ID
NCT01409603About darexaban + Naproxen
darexaban + Naproxen is a phase 1 stage product being developed by Astellas Pharma for Pharmacodynamic Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT01409603. Target conditions include Pharmacodynamic Interaction, Healthy Subjects.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01409603 | Phase 1 | Completed |
Competing Products
10 competing products in Pharmacodynamic Interaction